Accuray | ARAY - Operating Expenses

Stock Price
0.54
Daily Change
-0.02 -3.08%
Monthly
-33.90%
Yearly
-74.63%
Q1 Forecast
0.52

Accuray reported $37.18M in Operating Expenses for its fiscal quarter ending in December of 2024.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Accuray USD 37.18M 567K Dec/2024
AngioDynamics USD 81.98M 1.96M Feb/2025
Artivion USD 56.62M 195K Sep/2024
AtriCure USD 138.01M 3.95M Dec/2025
Boston Scientific USD 4.04B 18M Dec/2025
Edwards Lifesciences USD 1.2B 71.3M Dec/2025
Hologic USD 349.4M 447.1M Dec/2025
Inogen USD 49.14M 665K Sep/2024
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Orthofix International USD 10.89M 209.57M Sep/2024
Surmodics USD -245.35M 363.49M Sep/2024
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Trinity Biotech USD 14.82M 7.81M Sep/2025